Finbarr E. Cotter

6.8k total citations
111 papers, 5.0k citations indexed

About

Finbarr E. Cotter is a scholar working on Molecular Biology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Finbarr E. Cotter has authored 111 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Molecular Biology, 33 papers in Genetics and 31 papers in Pathology and Forensic Medicine. Recurrent topics in Finbarr E. Cotter's work include Chronic Lymphocytic Leukemia Research (31 papers), Lymphoma Diagnosis and Treatment (29 papers) and Acute Myeloid Leukemia Research (16 papers). Finbarr E. Cotter is often cited by papers focused on Chronic Lymphocytic Leukemia Research (31 papers), Lymphoma Diagnosis and Treatment (29 papers) and Acute Myeloid Leukemia Research (16 papers). Finbarr E. Cotter collaborates with scholars based in United Kingdom, United States and Switzerland. Finbarr E. Cotter's co-authors include David Cunningham, Paul A. Clarke, Andrew Webb, Florence I. Raynaud, Margherita Corbo, Zofia E. Dziewanowska, Paul J. Ross, Emanuele Zucca, Bryan D. Young and Justin S. Waters and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

Finbarr E. Cotter

111 papers receiving 4.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Finbarr E. Cotter United Kingdom 38 2.6k 1.3k 1.2k 872 848 111 5.0k
Jos Domen United States 33 3.6k 1.4× 1.8k 1.5× 1.3k 1.2× 608 0.7× 1.2k 1.4× 51 6.3k
Norihiko Kawamata Japan 38 2.2k 0.9× 1.4k 1.1× 745 0.6× 610 0.7× 745 0.9× 96 4.0k
Ruth Rimokh France 39 3.1k 1.2× 1.3k 1.0× 1.1k 0.9× 655 0.8× 454 0.5× 105 5.1k
Tobias Gedde‐Dahl Norway 39 1.8k 0.7× 770 0.6× 750 0.6× 651 0.7× 1.0k 1.2× 225 5.3k
Michael A. Rieger Germany 37 2.4k 0.9× 835 0.7× 525 0.5× 793 0.9× 1.1k 1.3× 145 4.9k
Massimo Geuna Italy 32 1.7k 0.7× 1.1k 0.9× 983 0.8× 1.1k 1.2× 336 0.4× 84 4.4k
Jude Fitzgibbon United Kingdom 37 1.7k 0.7× 965 0.8× 1.1k 1.0× 932 1.1× 1.3k 1.6× 112 4.2k
Vundavalli V. Murty United States 40 4.4k 1.7× 1.9k 1.5× 1.2k 1.1× 632 0.7× 585 0.7× 109 7.2k
Marcus B. Valentine United States 26 1.7k 0.6× 1.3k 1.0× 932 0.8× 322 0.4× 395 0.5× 39 3.6k
Carl W. Miller United States 41 2.8k 1.1× 1.7k 1.3× 430 0.4× 283 0.3× 764 0.9× 90 4.7k

Countries citing papers authored by Finbarr E. Cotter

Since Specialization
Citations

This map shows the geographic impact of Finbarr E. Cotter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Finbarr E. Cotter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Finbarr E. Cotter more than expected).

Fields of papers citing papers by Finbarr E. Cotter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Finbarr E. Cotter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Finbarr E. Cotter. The network helps show where Finbarr E. Cotter may publish in the future.

Co-authorship network of co-authors of Finbarr E. Cotter

This figure shows the co-authorship network connecting the top 25 collaborators of Finbarr E. Cotter. A scholar is included among the top collaborators of Finbarr E. Cotter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Finbarr E. Cotter. Finbarr E. Cotter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Patel, Salma, et al.. (2008). Gene expression changes in a zebrafish model of drug dependency suggest conservation of neuro-adaptation pathways. Journal of Experimental Biology. 211(10). 1623–1634. 126 indexed citations
2.
Auer, Rebecca, et al.. (2007). The 13q and 11q B‐cell chronic lymphocytic leukaemia‐associated regions derive from a common ancestral region in the zebrafish. British Journal of Haematology. 137(5). 443–453. 20 indexed citations
3.
Cotter, Finbarr E. & Rebecca Auer. (2007). Genetic alteration associated with chronic lymphocytic leukemia. Cytogenetic and Genome Research. 118(2-4). 310–319. 12 indexed citations
4.
Rinaldi, Andrea, Ivo Kwee, Monica Taborelli, et al.. (2005). Genomic and expression profiling identifies the B‐cell associated tyrosine kinase Syk as a possible therapeutic target in mantle cell lymphoma. British Journal of Haematology. 132(3). 303–316. 147 indexed citations
5.
Cotter, Finbarr E., Bo Su, Margherita Corbo, et al.. (2004). GCS-100, a Galectin 3 Antagonist, Is a Novel Caspase-9 Apoptosis Activating Agent for the Treatment of Indolent B-Cell Malignancies.. Blood. 104(11). 3286–3286. 2 indexed citations
6.
Banker, Deborah E., H. John Cooper, Dean A. Fennell, et al.. (2002). PK11195, a peripheral benzodiazepine receptor ligand, chemosensitizes acute myeloid leukemia cells to relevant therapeutic agents by more than one mechanism. Leukemia Research. 26(1). 91–106. 42 indexed citations
8.
Bertoni, Francesco, Michele Ghielmini, F. Cavalli, Finbarr E. Cotter, & Emanuele Zucca. (2002). Mantle Cell Lymphoma: New Treatments Targeted to the Biology. Clinical Lymphoma. 3(2). 90–96. 4 indexed citations
9.
Fennell, Dean A., et al.. (2001). Bcl-2 resistant mitochondrial toxicity mediated by the isoquinoline carboxamide PK11195 involves de novo generation of reactive oxygen species. British Journal of Cancer. 84(10). 1397–1404. 64 indexed citations
10.
Fennell, Dean A. & Finbarr E. Cotter. (2001). A Dynamical Systems Model to Simulate the Perturbation Kinetics of Gene Expression by Antisense Oligonucleotides. Journal of Theoretical Biology. 209(1). 103–112. 1 indexed citations
11.
Kuss, Bryone J. & Finbarr E. Cotter. (1999). Antisense - time to shoot the messenger. Annals of Oncology. 10(5). 495–504. 13 indexed citations
12.
Raynaud, Florence I., Rosanne M. Orr, Phyllis M. Goddard, et al.. (1997). Pharmacokinetics of G3139, a Phosphorothioate Oligodeoxynucleotide Antisense to bcl-2, after Intravenous Administration or Continuous Subcutaneous Infusion to Mice. Journal of Pharmacology and Experimental Therapeutics. 281(1). 420–427. 98 indexed citations
13.
Auer, Iwona, et al.. (1997). t(11;18)(q21;q21) is the most common translocation in MALT lymphomas. Annals of Oncology. 8(10). 979–985. 194 indexed citations
14.
Wilson, Alan, Finbarr E. Cotter, David Lowe, A G Stansfeld, & John D. Kirby. (1991). Mycosis fungoides in childhood: An unusual presentation. Journal of the American Academy of Dermatology. 25(2). 370–372. 17 indexed citations
15.
Cotter, Finbarr E., et al.. (1991). Direct sequence analysis of 14q+ and 18q− chromosome junctions at the MBR and MCR revealing clustering within the MBR in follicular lymphoma. Annals of Oncology. 2 Suppl 2. 93–97. 15 indexed citations
16.
Rohatiner, A. Z. S., C. G. A. Price, S.J. Arnott, et al.. (1991). Myeloablative therapy with autologous bone marrow transplantation as consolidation of remission in patients with follicular lymphoma. Annals of Oncology. 147–150. 4 indexed citations
17.
Cotter, Finbarr E., C. G. A. Price, Bryan D. Young, & T. Andrew Lister. (1990). Minimal residual disease in leukaemia and lymphoma. Annals of Oncology. 1(3). 167–170. 10 indexed citations
18.
Hiorns, Lynne R., et al.. (1989). Co‐incident N and K ras gene mutations in a case of AML, restricted to differing cell lineages. British Journal of Haematology. 73(2). 165–167. 10 indexed citations
19.
Cotter, Finbarr E.. (1988). Therapeutic milestones. International Journal of Clinical Practice. 42(5). 207–209. 3 indexed citations
20.
Cotter, Finbarr E., D. R. Bainbridge, & Adrian C. Newland. (1983). Neurological deficit associated with Mycoplasma pneumoniae reversed by plasma exchange.. BMJ. 286(6358). 22–22. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026